InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,354.03
(
1.18%
)
US TECH 100
18,558.40
(
0.09%
)
Dow Jones
38,807.33
(
0.25%
)
Brent Oil
78.58
(
0.02%
)
Bitcoin
70,943.54
(
-0.19%
)
Post# of 1990
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Schnauzer1

Send PM Follow Ignore
Followers 5
Posts 326
Boards Moderated 0
Alias Born 05/22/2015

Schnauzer1

Re: Schnauzer1 post# 101

Wednesday, 04/13/2016 2:36:56 PM

Wednesday, April 13, 2016 2:36:56 PM

Post# of 1990
Been so long since I reviewed this stock. I believe the Median overall survival of the P2 participants was 64 months longer than the standard of care. That is a bit different that 64% better. It is an enormous step up. The P3 is targeting on a four month MOS better than SOC. Really a powerful therapy. The best projected value from SA, that I have seen, is $56 share. That will develop once it passes P3.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up